Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
Go back to Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights| (NASDAQ: LTRN) | Delayed: 3.89 +0.10 (2.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.79 | 52 Week High | $ | |||
| Open | $3.84 | 52 Week Low | $ | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $3.77 | EPS | $ | |||
| Volume | 98,724 | |||||

